Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Neurol. Feb 28, 2012; 2(1): 1-10
Published online Feb 28, 2012. doi: 10.5316/wjn.v2.i1.1
Table 1 Demographic and clinical features of the patients with epilepsy, patients with comorbid depression and patients without comorbid behavioral disorders
Demographic and clinical featuresPatients (total) (n = 105)Patients with epilepsy and comorbid depression (n = 51)Patients with epilepsy and without comorbidpsychiatric disorders(n = 54)P-value
Male/female52/5320/3132/22-
Age; yr20-48 (30.87 ± 7.88)20-48 (30.37 ± 7.68)20-45 (31.40 ± 8.14)0.511
Age at onset of disease; yr1-40 (16.70 ± 8.68)1-35 (14.69 ± 7.90)3-40 (18.78 ± 9.05)0.02
Duration of illness; yr3-35 (13.89 ± 7.64)4-31 (15.31 ± 7.20)3-35 (12.42 ± 7.88)0.57
Family history of epilepsy (positive)17 (16.19%)10 (19.61%)7 (12.96%)-
Type of epilepsy:
GTC39 (37.14%)21 (41.18%)18 (33.33%)-
Complex partial/partial epilepsy with secondary generalization:66 (62.86%)30 (58.52%)36 (66.67%)-
Frontal26 (24.76%)11 (21.57%)15 (27.78%)
Temporal36 (34.29%)16 (31.37%)20 (37.04%)-
Parietal4 (3.81%)3 (5.88%)1 (1.85%)-
Side of epileptic foci:
Right29 (27.62%)15 (29.41%)14 (25.93%)-
Left37 (35.24%)15 (29.41%)22 (40.74%)-
AED(s) utilized
CBZ55 (52.38%)25 (49.02%)30 (54.7%)-
VPA28 (22.87%)11 (21.57%)17 (31.48%)-
Polytherapy22 (20.95%)15 (29.41%)7 (12.96%)-
Dose of AED(s) utilized; mg/d
CBZ400-1200 (764.62 ± 342.6)400-1200 (735.34 ± 358.5)400-1200 (722.34 ± 377.9)0.437
VPA200-1400 (783.27 ±425.5)200-1400 (777.27 ±400.2)200-1400 (750.28 ± 452.7)0.436
Duration of treatment; yr2-30 (9.08 ± 4.13)2-30 (9.12 ± 4.48)3-20 (9.04 ± 3.80)0.212
Serum drug level; µg/mL
CBZ3.50-12.80 (9.05 ± 3.3)3.50-12.80 (9.12 ± 4.5)3.50-11.9 (8.14 ± 3.6)0.924
VPA30.04-115.40 (85.88 ± 35.0)60.54-115.40 (80.64 ± 45.0)30.04-102.60 (70.74 ± 35.0)0.875
Degree of control on AED(s)
Controlled28 (26.67%)12 (23.53%)16 (29.63%)-
Partially controlled23 (21.90%)10 (19.61%)13 (24.07%)-
Uncontrolled54 (51.43%)29 (56.86%)25 (46.30%)-